Table 1.
Characteristic features of the optimized single drug PLGA NP and dual Drug PLGA Combo NP
Optimal | CDDP PLGA NP |
GMP PLGA NP |
GMP & CDDP PLGA Combo NP |
---|---|---|---|
DL (wt%) | 4.4 ± 0.6 | 4.2 ± 0.3 | 5.5 ± 0.8 |
EE (%) | 74.0 ± 10.0 | 69.5 ± 1.6 | 86.6 ± 1.9 & 92.4 ± 1.6 |
(n=3)